Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Wang, Lan ^a   Cheng, Zhong ^a   Gu, Ye ^a   Peng, Dingfeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT;

BLOOD CLOT LYSIS; BLOOD PRESSURE MONITORING; DRUG SAFETY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; META ANALYSIS; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; NO-REFLOW PHENOMENON; PATHOPHYSIOLOGY;

CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; DILTIAZEM; HUMANS; NO-REFLOW PHENOMENON; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VERAPAMIL;

EID: 84945312214     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/382086     Document Type: Review

References (32)

1. J. Schofer, R. Montz, and D. G. Mathey, "Scintigraphic evidence of the 'no reflow' phenomenon in human beings after coronary thrombolysis, " Journal of the American College of Cardiology, vol. 5, no. 3, pp. 593-598, 1985.
2. J. H. Chesebro, G. Knatterud, R. Roberts et al., "Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge, " Circulation, vol. 76, no. 1, pp. 142-154, 1987.
3. R. A. Kloner, C. E. Ganote, and R. B. Jennings, "The 'no reflow' phenomenon after temporary coronary occlusion in the dog, " The Journal of Clinical Investigation, vol. 54, no. 6, pp. 1496-1508, 1974.
4. R. N. Piana, G. Y. Paik, M. Moscucci et al., "Incidence and treatment of 'no-reflow' after percutaneous coronary intervention, " Circulation, vol. 89, no. 6, pp. 2514-2518, 1994.
5. K.M. Abbo, M. Dooris, S. Glazier et al., "Features and outcome of no-reflow after percutaneous coronary intervention, " The American Journal of Cardiology, vol. 75, no. 12, pp. 778-782, 1995.
6. R. A. Kloner, "No-reflow phenomenon: maintaining vascular integrity, " Journal of Cardiovascular Pharmacology and Therapeutics, vol. 16, no. 3-4, pp. 244-250, 2011.
7. H. Ito, A. Maruyama, K. Iwakura et al., "Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction, " Circulation, vol. 93, no. 2, pp. 223-228, 1996.
8. H. Ito and K. Iwakura, "Assessing the relation between coronary reflow and myocardial reflow, " The American Journal of Cardiology, vol. 81, no. 12, supplement 1, pp. 8G-12G, 1998.
9. M. A. Chaudhry, M. Smith, E. B. Hanna, and R. Lazzara, "Diverse spectrum of presentation of coronary slow flow phenomenon: a concise review of the literature, " Cardiology Research and Practice, vol. 2012, Article ID383181, 6 pages, 2012.
10. R. Berg andC. Buhari, "Treating and preventing no reflowin the cardiac catheterization laboratory, " Current Cardiology Reviews, vol. 8, no. 3, pp. 209-214, 2012.
11. G. N. Levine, E. R. Bates, J. C. Blankenship et al., "2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions, " Journal of the American College of Cardiology, vol. 58, pp. e44-e122, 2011.
12. R. M. Pomerantz, R. E. Kuntz, D. J. Diver, R. D. Safian, and D. S. Baim, "Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA, " Catheterization and Cardiovascular Diagnosis, vol. 24, no. 4, pp. 283-285, 1991.
13. F. J. Weyrens, J. Mooney, J. Lesser, and M. R. Mooney, "Intracoronary diltiazem for microvascular spasm after interventional therapy, "The American Journal of Cardiology, vol. 75, no. 12, pp. 849-850, 1995.
14. F. Jalinous, J. A. Mooney, and M. R. Mooney, "Pretreatment with intracoronary diltiazem reduces non-q-wave myocardial infarction following directional atherectomy, " The Journal of Invasive Cardiology, vol. 9, no. 4, pp. 270-273, 1997.
15. K. Saito, H. Nonogi, Y. Goto et al., "Antiischemic effect of intracoronary diltiazem onmyocardial ischemia during PTCA, " Heart and Vessels, vol. 11, no. 2, pp. 92-99, 1996.
16. Y. Taniyama, H. Ito, K. Iwakura et al., "Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction, " Journal of the American College of Cardiology, vol. 30, no. 5, pp. 1193-1199, 1997.
17. Q. Su, L. Li, and Y. Liu, "Short-Term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-Analysis of randomized controlled trials, " Clinical Cardiology, vol. 36, no. 8, pp. E11-E16, 2013.
18. Q. Su, T. S. Nyi, and L. Li, "Adenosine and verapamil for noreflow during primary percutaneous coronary intervention in people with acutemyocardial infarction, " Cochrane Database of Systematic Reviews, vol. 5, Article IDCD009503, 2015.
19. K. Vijayalakshmi, V. J. Whittaker, B. Kunadian et al., "Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes, " Heart, vol. 92, no. 9, pp. 1278-1284, 2006.
20. A. Hendler, A. Aronovich, E. Kaluski et al., "Optimization of myocardial perfusion after primary coronary angioplasty following an acute myocardial infarction. Beyond TIMI 3 flow, " The Journal of Invasive Cardiology, vol. 18, no. 1, pp. 32-36, 2006.
21. S.-F. Chang, J.-Y. Ma, J.-Y. Qian, X.-H. Shu, and J.-B. Ge, "Effects of intracoronary administration of nitroglycerin and verapamil for treatment of coronary slow flow phenomenon, " Zhonghua Xin Xue Guan Bing Za Zhi, vol. 38, no. 1, pp. 27-30, 2010.
22. D. Huang, J. Qian, L. Ge et al., "REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER), " American Heart Journal, vol. 164, no. 3, pp. 394-401, 2012.
23. L. Li, Y. Gu, T. Liu et al., "A randomized, single-center doubleblinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up, " PLoS ONE, vol. 7, no. 6, Article ID e38851, 2012.
24. I. Ozdogru, C. Zencir, A. Dogan et al., "Acute effects of intracoronary nitroglycerin and diltiazem in coronary slowflow phenomenon, " Journal of InvestigativeMedicine, vol. 61, no. 1, pp. 45-49, 2013.
25. I. F. Akturk, A. A. Yalcin, I. Biyik et al., "Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction, " Minerva Cardioangiologica, vol. 62, pp. 389-397, 2014.
26. A. R. Jadad, R. A. Moore, D. Carroll et al., "Assessing the quality of reports of randomized clinical trials: is blinding necessary?" Controlled Clinical Trials, vol. 17, no. 1, pp. 1-12, 1996.
27. P. Salinas, S. Jimenez-Valero, R. Moreno et al., "Update in pharmacological management of coronary no-reflow phenomenon, " Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 10, no. 3, pp. 256-264, 2012.
28. W. J. Elliott and C. V. S. Ram, "Calcium channel blockers, " Journal of Clinical Hypertension, vol. 13, no. 9, pp. 687-689, 2011.
29. V. Soukoulis, W. E. Boden, S. C. Smith, and P. T. O'Gara, "Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon, " Circulation Research, vol. 114, no. 12, pp. 1944-1958, 2014.
30. T. Reffelmann and R. A. Kloner, "The 'no-reflow' phenomenon: basic science and clinical correlates, " Heart, vol. 87, no. 2, pp. 162-168, 2002.
31. L. Galiuto, "Optimal therapeutic strategies in the setting of postinfarct no reflow: the need for a pathogenetic classification, " Heart, vol. 90, no. 2, pp. 123-125, 2004.
32. J.-L. Zhao, Y.-J. Yang, C.-J. Cui, S.-J. You, Y.-J. Wu, and R.-L. Gao, "Different effects of adenosine and calcium channel blockade on myocardial no-reflow after acute myocardial infarction and reperfusion, " Cardiovascular Drugs and Therapy, vol. 20, no. 3, pp. 167-175, 2006.